The ELF Test in Real-World Practice: From Laboratory Excellence to Clinical Action

Tuesday, July 28
11:30 a.m. – 12:30 p.m.
Exhibit Hall Theater 1
Presented by Siemens Healthineers

Overview

This informative session examines the role of the ELF® Test in real-world practice through a multidisciplinary lens. Each speaker will anchor their discussion on the importance of early risk assessment for disease progression in patients with advanced fibrosis due to metabolic dysfunction-associated steatohepatitis (MASH) and how non-invasive tests, such as the ELF Test, support earlier risk assessment and clinical action.

A hepatology perspective will explore how the ELF Test is used in the management of patients with MASH, including its role among non-invasive tests for assessing risk of disease progression and informing clinical decision-making. Complementing this view, a laboratorian will provide insight into the laboratory practices that ensure accurate, timely, and reliable ELF Test results.

Together, these perspectives emphasize the critical collaboration between clinical and laboratory teams and demonstrate how consistent testing quality, result interpretation, and information flow support confident decisions, decisive action, and continuity across the care pathway.

Moderator

Leontine Narcisse-Ogera, MD, PhD
SVP, Head of Medical and Scientific Strategy, Medical Communications
eNova

Speakers

Amreen M. Dinani, MD, MSc, FRCPC, ABOM
Associate Professor of Medicine; Division of Gastroenterology in the Department of Medicine
Duke University School of Medicine

Nikola A. Baumann, PhD, DABCC
Vice Chair of Quality, Department of Laboratory Medicine and Pathology;
Director of Central Clinical Laboratory and CLIA Lab Director
Mayo Clinic Laboratories